FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Mono Pharmacare IPO is a book built issue of Rs 14.84 crores. The issue is entirely a fresh issue of 53 lakh shares.
Mono Pharmacare IPO bidding started from August 28, 2023 and ended on August 30, 2023. The allotment for Mono Pharmacare IPO was finalized on Monday, September 4, 2023. The shares got listed on NSE SME on September 7, 2023.
Mono Pharmacare IPO price band is set at ₹26 to ₹28 per share. The minimum lot size for an application is 4000 Shares. The minimum amount of investment required by retail investors is ₹112,000. The minimum lot size investment for HNI is 2 lots (8,000 shares) amounting to ₹224,000.
Unistone Capital Pvt Ltd is the book running lead manager of the Mono Pharmacare IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for Mono Pharmacare IPO is Rikhav Securities.
Refer to Mono Pharmacare IPO RHP for detailed information.
IPO Date | August 28, 2023 to August 30, 2023 |
Listing Date | September 7, 2023 |
Face Value | ₹10 per share |
Price Band | ₹26 to ₹28 per share |
Lot Size | 4000 Shares |
Total Issue Size | 5,300,000 shares (aggregating up to ₹14.84 Cr) |
Fresh Issue | 5,300,000 shares (aggregating up to ₹14.84 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | NSE SME |
Share holding pre issue | 12,368,564 |
Share holding post issue | 17,668,564 |
Market Maker portion | 276,000 shares Rikhav Securities |
Mono Pharmacare IPO offers 5,300,000 shares. 500,000 (9.43%) to QIB, 2,260,000 (42.64%) to NII, 2,264,000 (42.72%) to RII.
Investor Category | Shares Offered |
---|---|
Anchor Investor Shares Offered | - |
Market Maker Shares Offered | 276,000 (5.21%) |
QIB Shares Offered | 500,000 (9.43%) |
NII (HNI) Shares Offered | 2,260,000 (42.64%) |
Retail Shares Offered | 2,264,000 (42.72%) |
Total Shares Offered | 5,300,000 (100%) |
Mono Pharmacare IPO opens on August 28, 2023, and closes on August 30, 2023.
IPO Open Date | Monday, August 28, 2023 |
IPO Close Date | Wednesday, August 30, 2023 |
Basis of Allotment | Monday, September 4, 2023 |
Initiation of Refunds | Tuesday, September 5, 2023 |
Credit of Shares to Demat | Wednesday, September 6, 2023 |
Listing Date | Thursday, September 7, 2023 |
Cut-off time for UPI mandate confirmation | 5 PM on August 30, 2023 |
Investors can bid for a minimum of 4000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 4000 | ₹112,000 |
Retail (Max) | 1 | 4000 | ₹112,000 |
HNI (Min) | 2 | 8,000 | ₹224,000 |
Lot Size Calculator |
Panilam Lakhatariya and Supal Lakhatariya are the company's promoters.
Share Holding Pre Issue | 81.02% |
Share Holding Post Issue |
Incorporated in 1994, Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products.
The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac - Diabetic medicines, and cosmocare products.
Mono Pharmacare works with contract manufacturers to manufacture pharmaceutical products to sell them under their brand name DLS Export. The company acquired DLS Export in 2022, for an aggregate consideration of ₹ 609 lakhs, in order to grow its product portfolio in selected therapeutic areas.
As on February 28, 2023, the company has over 168 pharmaceutical companies as their distributors and stockists and also, and served over 3,036 customers/vendors who are a mix of retail pharmacy stores as well as wholesalers.
Period Ended | 31 Mar 2020 | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
Assets | 871.70 | 1,122.46 | 1,438.31 | 6,257.39 |
Revenue | 1,168.90 | 2,837.83 | 3,710.27 | |
Profit After Tax | 1.99 | 9.51 | 35.09 | |
Net Worth | 201.92 | 369.58 | 427.57 | |
Reserves and Surplus | 131.71 | |||
Total Borrowing | 633.46 | 608.03 | 643.93 |
The market capitalization of Mono Pharmacare IPO is Rs 49.47 Cr.
KPI | Values |
---|---|
ROE | 9.01% |
ROCE | 10.34% |
Debt/Equity | 2.92 |
RoNW | 9.01% |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 1.99 | |
P/E (x) | 40 |
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
[Dilip Davda] The company is a distributor for many giant pharma companies and has been doing well for the reported periods. Based on FY23 earnings, the issue appears aggressively priced. Well-informed investors may park funds for the medium to long-term rewards. Read detail review...
The Mono Pharmacare IPO is subscribed 13.42 times on August 30, 2023 7:19:00 PM. The public issue subscribed 19.40 times in the retail category, 10.89 times in the QIB category, and 8.00 times in the NII category. Check Day by Day Subscription Details (Live Status)
Category | Subscription (times) |
---|---|
QIB | 10.89 |
NII | 8.00 |
Retail | 19.40 |
Total | 13.42 |
Total Application : 10,978 (19.40 times)
Listing Date | September 7, 2023 |
BSE Script Code | |
NSE Symbol | MONOPHARMA |
ISIN | INE0OIP01012 |
Final Issue Price | ₹28 per share |
Price Details |
---|
Final Issue Price |
Open |
Low |
High |
Last Trade |
NSE SME |
---|
₹28.00 |
₹29.00 |
₹29.00 |
₹30.45 |
₹30.45 |
Mono Pharmacare Limited
1A, Krinkal Apartment Opp.
Mahalaxmi Temple, Paldi
Ahmedabad -380007
Phone: +91 99780 41356
Email: cs@monopharmacareltd.com
Website: https://monopharmacareltd.com/
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide
Mono Pharmacare IPO is a SME IPO of 5,300,000 equity shares of the face value of ₹10 aggregating up to ₹14.84 Crores. The issue is priced at ₹26 to ₹28 per share. The minimum order quantity is 4000 Shares.
The IPO opens on August 28, 2023, and closes on August 30, 2023.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Mono Pharmacare IPO using UPI as a payment gateway. Zerodha customers can apply in Mono Pharmacare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Mono Pharmacare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Mono Pharmacare IPO opens on August 28, 2023 and closes on August 30, 2023.
Mono Pharmacare IPO lot size is 4000 Shares, and the minimum amount required is ₹112,000.
You can apply in Mono Pharmacare IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Mono Pharmacare IPO will be done on Monday, September 4, 2023, and the allotted shares will be credited to your demat account by Wednesday, September 6, 2023. Check the Mono Pharmacare IPO allotment status.
Useful Articles
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
1) BULK 07-SEP-2023 NIRAJ RAJNIKANT SHAH BUY 2,24,000 30.44
2) BULK 07-SEP-2023 TOUCHLINE SECURITIES PRIVATE LIMITED BUY 1,60,000 29.00
3) BULK 07-SEP-2023 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED BUY 1,00,000 29.00 -
4) BULK 07-SEP-2023 B.W.TRADERS BUY 3,00,000 29.00 -
5) BULK 07-SEP-2023 YOGESHKUMAR RASIKLAL SANGHAVI BUY 1,00,000 29.00 -